LGBT Cancer Project

Therapeutic Areas: Oncology | Immunology | Hematology

Non-Hodgkin's Lymphoma Clinical Trials

A listing of Non-Hodgkin's Lymphoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Kentucky

UPDATED

Louisville Kentucky 40207

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

New York

NEW

Biomedical Research Alliance of New York
Bronx New York 10467

Diffuse Large B Cell/Non-Hodgkin Lymphoma

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Ohio

UPDATED

Canton Ohio 44718

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Utah

UPDATED

Salt Lake City Utah 84106

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Washington

UPDATED

Spokane Washington 99208-1129

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Argentina

UPDATED

Buenos Aires Ciudad Auton. de Buenos Aires C1431FWO

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Cordoba X5000AOQ

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Australia

UPDATED

Ballarat Victoria 3350

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Nedlands 6009

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Austria

UPDATED

Graz Steiermark 8036

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Wien 1130

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Brazil

UPDATED

Barretos Sao Paulo 14784400

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Jaú Sao Paulo 17210-120

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Passo Fundo Rio Grande do Sul 99010-260

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Porto Alegre Rio Grande do Sul 90110-270

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Sao Paulo 05651-901

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

São Paulo Sao Paulo 08270-070

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

São Paulo Sao Paulo 01236-030

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Bulgaria

UPDATED

Plovdiv 4002

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Sofia 1756

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Varna 9010

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Chile

UPDATED

Temuco Araucanía 4810469

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

China

UPDATED

Beijing 100071

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Beijing 100050

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Changchun Jilin

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Chengdu Sichuan 610041

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Guangzhou Guangdong 510060

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Hangzhou Zhejiang 310003

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Hangzhou Zhejiang 310022

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Nanjing Jiangsu 210009

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Shanghai 200030

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Shengyang Liaoning 110042

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Suzhou Jiangsu 215006

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Tianjin

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Tianjin 300121

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Colombia

UPDATED

Medellín Antioquia

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

France

UPDATED

Bayonne 64100

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Brest 29470

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Nantes 44805

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Pessac 33600

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Poitiers 86021

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Germany

UPDATED

Berlin 10967

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Dresden Sachsen 01307

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Halle Sachsen-Anhalt 06120

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Munich Bayern 81377

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Recklinghausen Nordrhein-Westfalen 45657

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

Greece

UPDATED

Athens 106 76

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Athens 115 26

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Haidari 12462

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)